home / stock / ttoo / ttoo quote
Last: | $0.1478 |
---|---|
Change Percent: | -23.97% |
Open: | $0.11 |
Close: | $0.1944 |
High: | $0.155 |
Low: | $0.11 |
Volume: | 11,504,755 |
Last Trade Date Time: | 02/11/2025 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.1478 | $0.11 | $0.1944 | $0.155 | $0.11 | 11,504,755 | 02-11-2025 |
$0.1944 | $0.2166 | $0.1944 | $0.22 | $0.1825 | 3,208,724 | 02-10-2025 |
$0.21 | $0.21 | $0.21 | $0.22 | $0.2061 | 977,188 | 02-07-2025 |
$0.21 | $0.225 | $0.21 | $0.229 | $0.2056 | 1,835,074 | 02-06-2025 |
$0.222 | $0.24 | $0.222 | $0.24 | $0.2108 | 1,425,999 | 02-05-2025 |
$0.23 | $0.23 | $0.23 | $0.24 | $0.22 | 1,298,296 | 02-04-2025 |
$0.227 | $0.216 | $0.227 | $0.23 | $0.2015 | 1,357,402 | 02-03-2025 |
$0.215 | $0.21 | $0.215 | $0.22 | $0.2094 | 1,485,663 | 01-31-2025 |
$0.21 | $0.22 | $0.21 | $0.2257 | $0.2089 | 688,628 | 01-30-2025 |
$0.22 | $0.2325 | $0.22 | $0.2361 | $0.2181 | 781,357 | 01-29-2025 |
$0.23 | $0.24 | $0.23 | $0.24 | $0.2212 | 933,632 | 01-28-2025 |
$0.2336 | $0.241 | $0.2336 | $0.25 | $0.226 | 846,065 | 01-27-2025 |
$0.25 | $0.254 | $0.25 | $0.2586 | $0.24 | 930,044 | 01-24-2025 |
$0.246 | $0.239 | $0.246 | $0.27 | $0.2301 | 4,992,423 | 01-23-2025 |
$0.2292 | $0.2198 | $0.2292 | $0.2498 | $0.216 | 1,554,837 | 01-22-2025 |
$0.2299 | $0.28 | $0.2299 | $0.28 | $0.2286 | 2,162,157 | 01-21-2025 |
$0.26 | $0.2525 | $0.26 | $0.28 | $0.2525 | 917,061 | 01-20-2025 |
$0.26 | $0.2525 | $0.26 | $0.28 | $0.2525 | 917,061 | 01-17-2025 |
$0.26 | $0.29 | $0.26 | $0.29 | $0.25 | 1,033,846 | 01-16-2025 |
$0.28 | $0.3 | $0.28 | $0.3089 | $0.28 | 806,858 | 01-15-2025 |
News, Short Squeeze, Breakout and More Instantly...
LEXINGTON, Mass., Jan. 07, 2025 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ: TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced preliminary unaudited financial and operational results for the f...
LEXINGTON, Mass., Dec. 18, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ: TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced the sale of four T2Dx ® Instruments to its European (EU) distributor that represents m...
LEXINGTON, Mass., Dec. 17, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ: TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced that it has surpassed the shipment of 250,000 sepsis tests, marking a significant milestone tha...